The store will not work correctly when cookies are disabled.
N,N-dimethyl-2-(6-(6-(trifluoromethyl)pyridin-2-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide
ID: ALA4462073
PubChem CID: 124176295
Max Phase: Preclinical
Molecular Formula: C17H15F3N4O
Molecular Weight: 348.33
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)C(=O)Cn1ccc2ncc(-c3cccc(C(F)(F)F)n3)cc21
Standard InChI: InChI=1S/C17H15F3N4O/c1-23(2)16(25)10-24-7-6-13-14(24)8-11(9-21-13)12-4-3-5-15(22-12)17(18,19)20/h3-9H,10H2,1-2H3
Standard InChI Key: MNKQUDROCZIINF-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
4.2290 -2.1915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2278 -3.0111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9359 -3.4200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9341 -1.7827 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6427 -2.1879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6475 -3.0065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4275 -3.2550 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9049 -2.5899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4198 -1.9305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6846 -4.0307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4849 -4.1960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7419 -4.9717 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0282 -3.5855 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1987 -5.5821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5422 -5.1369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5198 -3.4191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8140 -3.0085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1065 -3.4159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1054 -4.2339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8178 -4.6429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5224 -4.2332 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8200 -5.4601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1134 -5.8706 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.5288 -5.8668 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.8148 -6.2734 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
7 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
12 15 1 0
2 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
20 22 1 0
22 23 1 0
22 24 1 0
22 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 348.33 | Molecular Weight (Monoisotopic): 348.1198 | AlogP: 3.21 | #Rotatable Bonds: 3 |
Polar Surface Area: 51.02 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.92 | CX LogP: 2.66 | CX LogD: 2.66 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.73 | Np Likeness Score: -1.91 |
References
1. Chrovian CC, Soyode-Johnson A, Wall JL, Rech JC, Schoellerman J, Lord B, Coe KJ, Carruthers NI, Nguyen L, Jiang X, Koudriakova T, Balana B, Letavic MA.. (2019) 1H-Pyrrolo[3,2-b]pyridine GluN2B-Selective Negative Allosteric Modulators., 10 (3): [PMID:30891123] [10.1021/acsmedchemlett.8b00542] |